Neural stem cells (NSCs) obtained from the midbrain region of embryonic (E14) mice were initially cultured with basic fibroblast growth factor (bFGF), Sonic hedgehog, and FGF-8 in a serum-free N-2 culture medium to foster differentiation into a serotonergic-like phenotype. During the initial differentiating phase, these progenitor cells expressed En1, Pax3, and Pax5 mRNA. Subsequently, a single serotonin [5-hydroxytryptamine (5-HT)] and tryptophan hydroxylase-positive clone was isolated, which gave rise to cells that developed serotonergic properties. Sixty percent of these progenitor cells expressed the serotonin transporter (SERT), as indicated by specific ligand binding of [
NSCs from fetal telencephalon resulted in multipotent cells, which replaced defective neurons and responded to normal developmental cues and also expressed foreign genes in vivo (13) . Recent studies have also reported that human adipose tissue-derived stromal cells, transplanted into rats with cerebral ischemia, corrected the neurological deficits. In addition, brain lysosomal storage pathology in the acid sphingomelinase knockout (KO) mouse model was reversed by direct intracerebral transplantation of neural progenitor cells (14) . All of these findings indicate that stem cells might be useful for future therapeutic cloning and cell transplantation (15) (16) (17) (18) (19) (20) (21) .
In studies of mammalian brain development, it has been found that the specification of two prominent neuronal neurotransmitter cell types, dopaminergic (DA) and serotonergic [5- hydroxytryptamine (5-HT)] neurons (22, 23) , is associated with the development of the midbrain and hindbrain (24) . Although NSC research has developed many different cell phenotypes, including DA stem cells that can rescue dysfunctional neurons (1, (25) (26) (27) (28) (29) (30) (31) , only one report has described stem cells that exhibit similarities to CNS serotonin neurons; this was an in vitro study of monkey embryonic stem cells using neuronal and serotonergic markers and did not include investigations of serotonin transporter (SERT) binding sites or 5-HT transport (32) . As the brain serotonergic system participates in the coordination of complex sensory and motor patterns that are associated with different behavioral states and implicated in multiple neuropsychiatric disorders, it seems important to establish a serotonergic-like stem cell system. Furthermore, it would seem important to examine whether these stem cells possessed specific SERT functions, as the uptake and recycling of 5-HT by SERT are the most important regulators of the effects of 5-HT at the 14-plus 5-HT receptors, and SERT is the target molecule for the treatment of the largest number of neuropsychiatric disorders in the world. These disorders include depression, bipolar disorder, schizophrenia, anxiety disorders including obsessive-compulsive disorder, chronic pain syndrome, eating disorders, and autism.
In this present study, the aim was to examine the differentiation of NSC into a serotonergic-like phenotype in vitro and then to implant those differentiated cells into the brain of mice with a genetic lack of SERT. Critical issues include choice of specific growth factors and serum-free medium, most appropriate to promote differentiation into a neuronal versus glial phenotype; selection of 5-HT and tryptophan hydroxylase (TPH)-positive, single clonal spheres by two times subcloning using a limiting dilution culture procedure; demonstration of the biological function of SERT by [ 3 H]-5-HT uptake in cells; and assessment of the survival of these implanted progenitor cells and their expressed SERT gene in the target brain region. We studied whether the implanted serotonergic-like progenitor cells would survive and if so, how long they would maintain the same phenotype and express SERT in the adult brain of SERT KO mice.
MATERIALS AND METHODS

Isolation and cultures of neural progenitor cells
Pregnant mice were killed by exposure to CO 2. The surgical site was sterilized using 70% ethanol, and fine scissors and forceps were used to make a cut through the length of the uterine horn. Then, each embryo, along with the placenta, was removed and transferred to a 100-mm 2 plastic Petri dish. The midbrain region tissue was isolated from the head of embryonic (E14) mice. Tissue was minced and dissociated in 1800 U/ml trypsin (Sigma Chemical Co., St. Louis, MO, USA) at 37°C for 10 min, after the addition of 200 U/ml DNase I (Sigma Chemical Co.) and 3600 U/ml soybean trypsin I inhibitor (Life Technologies, Gaithersburg, MD, USA) to the suspension. Cells were triturated 25 times using a 5-ml pipette. Then the cells were transferred to a 4% bovine serum albumin (BSA) medium to remove cellular debris by centrifugation. Cells (5×10 5 cells/ ml) were seeded onto poly-D-lysine/laminin-coated tissue-culture plates containing leukemia inhibitor factor (1400 U/ml, Gibco/BRL, Grand Island, NY, USA) and basic fibroblast growth factor (bFGF; Cat: 233-Fb-025, R&D Systems, Minneapolis, MN, USA) with KO Dulbecco's minimal essential medium (DMEM; Cat: 10892-018, Gibco/BRL). The medium was supplemented with 100 mM DMEM nonessential amino acids, 0.55 mM 2-mercaptoethanol, 2.5 mM L-glutamine, N-2 supplement, and antibiotics (all from Gibco/BRL). In addition to the serum-free culture medium, we added 10 ng/ml FGF-8 (Cat: 423-F8, R&D Systems) and Sonic hedgehog (Shh; Cat: 461-SH, R&D Systems) every day to induce the cells to differentiate into serotonergic neurons. The medium was changed every 2-3 days.
After 7-10 days of culture, primary spheres were dissociated by medium containing 0.05% trypsin plus 0.04% EDTA (Gibco/BRL). Expanded spheres were dispersed into suspensions containing single cells by trituration and then cultured on 24-well plates at a density of 1, 10, 20, and 40 cells per well by limiting dilution. These cells proceeded to grow in the well, and single spheres were marked. Thereafter, the single-sphere cells were expanded and repassaged into two plates. The first plate of cells were continued for further culture. The second plate of cells was grown in the coverslips prior to coating with poly-D-lysine. These cells were examined by immunofluorescent staining with Nestin, A2B5, anti-neuronal nuclei (NeuN), glial fibrillary acidic protein (GFAP), 5-HT, and TPH neuronal marker antibodies.
Immunofluorescent staining
Cells were washed with phosphate-buffered saline (PBS) and fixed in cold methanol for 20 min at room temperature. Fixed cultures were incubated with one of the following antibodies, which were diluted in PBS containing 1% BSA and 0.025% Triton X-100. Antibodies and dilutions were as follows: rabbit anti-Nestin-130 polyclonal antibody 1:50 [National Institute of Neurological Disorders and Stroke (NINDS), National Institutes of Health (NIH), Bethesda, MD, USA], mouse anti-A2B5 monoclonal antibody (mAb) 10 μg/ml, mouse anti-bromodeoxyuridine (BrdU) mAb 50 μg/ml (Amersham Pharmacia Biotech, Little Chalfont, UK), rabbit anti-GFAP polyclonal antibody 1:80 (Sigma Chemical Co.), rabbit anti-serotonin polyclonal antibody 1:800 (Sigma Chemical Co.), tyrosine hydroxylase (TH) mAb 1:1000 (Sigma Chemical Co.), TPH mAb 1:500 (Sigma Chemical Co.), and mouse NeuN mAb 1:200 (MAB377, Chemicon International, Temecula, CA, USA). Immunofluorescent staining was carried out using a modified standard protocol. The samples were blocked with 10% normal goat serum plus 0.3% Triton X-100 in 0.01 M PBS at 37°C for 30 min. Incubations with primary antibodies were carried out at 37°C for 1 h and transferred to 4°C overnight. After the cells were washed the next day, the cells were incubated with secondary antibodies at 37°C for 2 h. Fluorescent doublelabeling was performed with the secondary antibodies, goat anti-mouse immunoglobulin G (IgG)-fluorescein isothiocyanate (FITC) 1:25 and goat anti-rabbit IgG-Tex-Red 1:50 (Accurate Chemical & Scientific Corp., Westbury, NY, USA). Immunostaining was analyzed with the "Fluoview" confocal laser-scanning microscope (Olympus).
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Electrophysiological measurements
Currents were recorded using the whole-cell patch-clamp technique. The cells grown on 12 mm glass coverslips were transferred to recording medium (130 mM NaCl, 4 mM KCl, 2 mM CaCl, 2 mM MgCl 2, 10 mM HEPES, 10 mM glucose). Patch electrodes were fire-polished and had resistances in the range of 3.5-4.5 MQ when filled with pipette solution. Currents were amplified, and cell membrane capacitance and series resistance were compensated electronically using Axopatch 200A. Signal was low pass-filtered at 2 KHz. All experiments were performed at room temperature.
Reverse transcriptase-polymerase chain reaction (RT-PCR)
Total cellular RNA was prepared using the RNAeasy total RNA purification kit (Qiagen, Valencia, CA, USA). RNA solution (10 μl) was heated to 65°C for 10 min and then chilled on ice. The cDNA was synthesized using 2 μg total RNA in a 15-μl reaction volume, using the firststrand cDNA synthesis kit (Amersham Pharmacia Biotech). The cDNA synthesis was carried out using Moloney murine leukemia virus RT. The PCR was carried out using standard protocols with Taq polymerase (Gibco/BRL). The cycling parameters program was as follows: denaturation at 95°C for 5 min and annealing at 94°C and 59°C for 30 s and at 72°C for 1 min and 30 s. 
Measurement of [
H]-5-HT uptake
These serotonergic-like progenitor cells were transferred to poly-D-lysine-coated six-well plates 4 or 5 days prior to uptake experiments. During subculture of cells, the culture medium was replaced once by fresh medium. On the experimental day, the culture plate containing a confluent monolayer of cells (~3×10 6 cells/well) was taken out of the incubator and kept at room temperature for 1 h. Following this stabilization period, the culture medium was aspirated, and the cells were washed twice with the uptake buffer containing 137 mM NaCl, 2.7 mM KCl, 4.3 mM Na 2 HPO 4 , 1.4 mM KH 2 PO 4 , 0.4 mM CaCl 2 , 1 mM MgCl 2 , and 5 mM d-glucose at pH 7.3. Then, the cells were pre-equilibrated with 1 ml uptake buffer for 10 min at 37°C. In experiments to determine the effect of Na + -free ions, additional buffer was used, in which all Na + ions were replaced isotonically by Li + , and pH was adjusted to 7.3 with LiOH. For 5-HT uptake quantification, the cells were incubated for 5 min with 1 ml uptake buffer containing 50 nM 5-HT substrate, in which one part of radiolabeled 5-HT ([ 3 H]-5-HT, Perkin Elmer, Wellesley, MA, USA, 30 Ci/mmole) was mixed with nine parts of cold 5-HT. Uptake of [
3 H]-5-HT into cells was terminated by aspirating the buffer and subsequently washing the cells four times with 2 ml icecold PBS. The cells were lysed with 2 ml PBS containing 0.5% sodium dodecyl sulfate (SDS) for 60 min at room temperature. Aliquots of the lysate samples (1.5 ml) were transferred to scintillation vials for determination of radioactivity. 
SERT binding assay
The binding assay proceeded with modifications of procedures as published previously (36, 37 7 per dish) were treated with two doses (10 and 20 ng/ml) of brain-derived neurotrophic factor (BDNF; Cat: 248-BD-005, R&D Systems) for 24 h. The cells were then collected using centrifugation at 1500 rpm for 5 min, and the cell pellets were resuspended with hypotonic buffer (15 mM Tris, 2.5 mM MgCl 2, 0.2 mM EDTA, pH 7.4). Following this, homogenates prepared from the cell membranes were centrifuged at 20,000 g for 10 min. The cell pellets were resuspended with 50 mM Tris-HCl buffer containing 2 mM MgCl 2, pH 7.4 . All assays were performed in triplicate using a final volume of 0.2 ml membrane proteins in buffer. Samples were incubated with [
125 I]-RTI-55 ligand concentration (1.5 nM) at 37°C for 60 min. Nonspecific binding (NSB) was determined in the presence of 10 μM fluoxetine (Cat: F-132, Sigma Chemical Co.) and 10 μM of the dopamine uptake inhibitor, GBR 12909 (Cat: G-2285, Sigma Chemical Co.), for plasma membrane SERT and dopamine transporter (DAT), respectively. The binding was terminated by an addition of 0.8 ml ice-cold assay wash buffer. The binding reaction samples were then washed twice with icecold assay wash buffer and centrifuged at 20,000 g for 10 min. The binding samples were placed in tubes, and the reactivity was measured by counting. Further analysis was counted out with RiaCalc WIZ, Program 3.6.
Animals
Mice with a targeted disruption of SERT on a C57/BL6 background had originally been generated in our laboratory by homologous recombination, as reported previously (37) . The SERT KO mice used in the present studies were 3-month-old females from the F9 generation with body weights of 25-30 g. The mice were housed in groups of four to five per cage in a temperature-and light-controlled room (12 h light/dark, lights on at 6 AM). Experimental animal protocols were approved by the National Institute of Mental Health, Animal Care and Use Committee (NIH).
Immunohistochemical study using implanted, serotonergic-like progenitor cells in SERT KO mice brains
To further examine serotonergic-like progenitor cells in vivo, expanded cells were labeled with 10 μM BrdU (Roche Diagnostics, Nutley, NJ, USA) for 24 h before the preparation of cells for transplantation. The cultures were trypsinized for 3 min and then washed with PBS. Cells were collected by centrifugation at 1500 rpm for 5 min and resuspended in 0.5-1 ml KO-DMEM-N-2 medium. To examine the cell viability, an aliquot of the suspension was transferred and mixed
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with trypan blue. The cell suspension was centrifuged a second time and resuspended in a smaller volume of medium to provide a high density of 10 4 cells in 1 μl PBS containing 20 ng Shh/ml and FGF-8/ml. For the transplantation study, a total of 32 adult C57/B6 female mice, aged 2-3 months, of two genotypes [16 wild-type (WT) mice, 16 SERT-KO mice] was used. The mice were anesthetized with avertin (0.15 ml/10 g intraperitoneally). A total of 2 × 10 4 cells was stereotaxically injected into the hippocampus at the following coordinates: hippocampus = bregma-2.3 mm; left, 1.8 or 1.85 mm; deep, -2.3 mm, as calculated from bregma and the skull surface. The skin was opened, and the skull was delicately bored with a micro-drill (Fine Science Tools, Inc., North Vancouver, B.C., Canada, No. 18000-17). Mice were injected with total 2 μl cells and concentrated lentiviral stock or vehicle control with medium slowly infused at the speed of ~0.1 μl/min by using a microinjection CMA/100 microdialysis pump (made in Sweden, Serial No. 3139).
At 2, 4, and 8 weeks (n=4) after transplantation, two of the animals in each group were perfused with 4% paraformaldehyde (PFA) in PBS solution. The brains were maintained with 4% PFA in PBS solution containing 20% sucrose at 4°C for 24 h. Then the brains were then put into a 0.01-M PBS solution containing 30% sucrose at 4°C until they sank. Free-floating coronal frozen microtome sections (40 μm) were prepared from each brain. For immunofluorescence staining with BrdU antibody, the brain sections were pretreated in 50% formamide for 2 h, twice with saline sodium citrate at 65°C, and then incubated with 2 M HCl at 37°C for 30 min. The sections were stained with anti-BrdU fluorescence (Cat: 1 202 693, Roche Diagnostics) 50 μg/ml in PBS. To examine the distribution of transplanted cells, hippocampal semiserial sections (every fifth or 10th section) were stained with BrdU antibody. Those cells positively stained with BrdU were quantitated using a counting procedure in different locations. Hippocampus sections containing the transplants were examined for protein expression of SERT by Western blot.
Vector constructs and virus production
Dr. Zhennan Lai (Development and Metabolic Neurology Branch, NINDS, NIH) kindly provided the human immunodeficiency virus (HIV)-enhanced green fluorescent protein (EGFP) lentiviral vector used in the implantation study (38) . The pUL49ep BamHI fragment was cloned into the EGFP coding region present in plasmid EGFP-N1 (Clontech, Palo Alto, CA, USA). Virus was produced in 293T cells by transient transfection as described previously (39) . Finally, the high titer virus stocks were concentrated by ultracentrifugation. The titer of viral vectors was determined by infecting 1 × 10 5 293T cells with serial dilutions of the concentrated supernatant. A total volume of 2 × 10 4 cells in 2-μl high titer viral vector was injected into the brain to study the survival of these serotonergic-like stem cells after implantation for 8 weeks.
Western blot analysis
The brain tissue protein was extracted in a lysis solution containing 1% Triton X-100, 0.1% SDS, 0.1 M NaCl, 0.5% deoxycholic acid, 1 mM phenylmethylsulfonyl fluoride, and 10 mM Tris-HCl, pH 8.0. Protein concentrations for each sample were quantified using the Bio-Rad method. Each sample obtained from each of different time-points and the transplant sites (50 μg protein) was run on an 8-16% Tris-glycine-SDS polyacrylamide gel (Invitrogen Corp., Novex, Carlsbad, CA, USA). After transfer to polyvinylidene difluoride membrane, Western blot procedure was performed using anti-SERT antibody 1:700 dilution (Santa Cruz Biotechnology, Santa Cruz, CA, USA, ST-C20), anti-vesicular monoamine transporter type 2 (VMAT2) antibody 1:500 dilution (Chemicon International, AB1596), β-actin antibody 1:2000 dilution (Sigma Chemical Co., A5441), and enhanced chemiluminescent signal detection (Amersham Pharmacia Biotech).
Statistical analysis
All studies were performed at least three times using cells prepared at different times. For studies in which cell counting was performed, at least 300 cells were counted on coverslips for the differentiation study, and five fields for each coverslip were counted after doubleimmunostaining. Statistical analysis was performed using Student's t-test. Average data from separate experiments were shown as means ± SEM. Statistical significance was defined as P < 0.05. Analysis of the results of treatment with two doses of BDNF on binding of [ 125 I]-RTI-55 to SERT was performed using one-way ANOVA followed by a Bonferroni post-hoc test using StatView (SAS Institute, Cary, NC, USA). Significance levels were denoted as ***P < 0.001.
RESULTS
Differentiation and characterization of the serotonergic-like progenitors isolated from NSCs
We first investigated undifferentiated NSCs, which were isolated from the midbrain region of embryonic (E14) mice. These NSCs were initially cultured with bFGF and N-2 in KO serum-free DMEM. Shh and FGF-8 were added every day to induce cells to differentiate into serotonergiclike neuronal cells. We studied phenotypical expression in primary spheres using specific neuronal antibodies. At 2 weeks, 95 ± 5% of these cells were stained with Nestin, 15 ± 2% with GFAP, 3 ± 1% with A2B5, and 0.5 ± 0.3% with TH markers. The cells that had positive staining with 5-HT antibody increased from 0.4 ± 0.2% (2 weeks) to 65 ± 6% (8 weeks) during the period of differentiation (Fig. 1A) .
We next studied the expanded spheres, which were dispersed into suspensions containing single cells and cultured on well plates at different densities per well by limiting dilution. These cells proceeded to grow in the well, and single spheres were marked. Thereafter, the single-sphere cells were expanded and repassaged into two plates. The first plate of cells was maintained as cultures. The second plate of cells was grown on the coverslips prior to coating with poly-Dlysine. The selected serotonergic-like single clones (Fig. 1B) were double immunofluorescencestained with 5-HT and TPH antibodies, revealing that 5-HT and TPH were colocalized in the cytoplasm of these serotonergic-like progenitor cells. These 5-HT/TPH-positive progenitor cells were also stained with the specific neuronal nuclear protein NeuN antibody (Fig. 1C) . Furthermore, RT-PCR results showed that these serotonergic progenitor cells at 10 weeks expressed mRNA of several genes associated with DA and serotonergic neurons at early stages of CNS development. The Pax3, Pax5 (33, 34, 40) , and homeobox transcription factor En1 (35) were expressed in these cells. The G3PDH housekeeping gene was also clearly expressed higher in these serotonergic-like progenitor cells (Fig. 1D) .
Selection of serotonergic-like progenitor cells that expressed glutamate-and γ-aminobutyric acid (GABA)-sensitive ion channels
To select a majority of serotonergic-like progenitor cells, we used a procedure based on serial limiting dilution and culture subcloning for purifying these multipotency cells. We found that the individual clone cells grew rapidly and exhibited a round shape and size similar to each other. The cell number increased without showing any axon extensions (Fig. 2Aa-d, upper panel) . Six weeks later, after the clone cells had been repassaged into two plates with serum-free medium containing of 10 ng/ml FGF-8 and Shh-N every day, the expanded cells exhibited axonal extensions with interconnections ( Fig. 2Aa-d, lower panel) .
A recent study indicates that there are glutamate-gated and GABA-gated ion channels in serotonergic neurons (41) . To determine whether these serotonergic-like progenitor cells have such ligand-gated ion channels, cells cultured for 10 weeks were patch-clamped to examine glutamate-and GABA (1 mM)-induced inward currents electrophysiologically. Glutamate (Fig.  2B) and GABA (Fig. 2C ) induced fast, inward currents when cells were voltage-clamped at -70 mV. These findings indicated that these serotonergic progenitor cells expressed glutamate-and GABA-sensitive ion channels. The results indicate that these serotonergic-like progenitors present a pluripotent capacity during their differentiated stages.
SERT expressed in serotonergic-like progenitor cells is indicated by [ 125 I]-RTI-55 ligand binding
We evaluated whether 10-week-old progenitor cells expressed SERT using [
125 I]-RTI-55, a sensitive ligand for the 5-HT transporter. As [
125 I]-RTI-55 binds to SERT and the DAT, SERTspecific binding (SB) was determined using 10 μM GBR 12909 to block DAT; NSB was determined using 10 μM fluoxetine. The serotonergic-like progenitor cells exhibited a high SERT [
125 I]-RTI-55 SB of 297 fmol/mg protein at a substrate concentration of 1.5 nM (Fig. 3A) . To determine whether these serotonergic progenitor cells respond to BDNF, the serotonergic-like progenitor cells were pretreated with 10 ng/ml and 20 ng/ml BDNF or vehicle control in the culture media for 24 h. The results showed that [
125 I]-RTI-55 binding was significantly increased (***, P<0.001) following both doses of BDNF treatment compared with the vehicle control group (Fig. 3B) . These findings suggest that BDNF plays a role, not only in promoting cell survival and differentiation but also in up-regulating the expression of the SERT gene in these serotonergic progenitor cells.
Function of SERT verified in serotonergic-like progenitors by uptake of [ 3 H]-5-HT
To study a specific transport function of these serotonergic-like progenitor cells, [ 3 H]-5-HT uptake was measured in a confluent monolayer of cells. Figure 3C demonstrates that 82% and 40% of total transport of 5-HT depended on temperature and Na + ions, respectively. Furthermore, when 5-HT transporter inhibitors were used to assess the specific uptake of 5-HT, Na + -dependent 5-HT uptake was reduced 95% by fluoxetine and citalopram, selective serotonin reuptake inhibitors (SSRIs; Fig. 4A ). The tricyclic imipramine also caused a profound inhibition (>90%). These results, taken together, demonstrated that SERT expressed in these serotonergiclike progenitor cells have sodium-dependent uptake of 5-HT, which is sensitive to inhibition by various selective SERT inhibitors.
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Implantation of serotonergic-like progenitors into SERT KO mice brains
The above in vitro studies demonstrated that these stable lineages of progenitor cells expressed SERT binding sites and showed 5-HT uptake function. To determine whether the lineage progenitor cells might survive and keep their phenotype in vivo, we implanted them into the brain of mice lacking SERT. We examined the survival of these progenitor cells following implantation of EGFP-lentiviral vector infected with progenitor cells in the hippocampus. Eight weeks following implantation, brain sections showed that the most dense localization of the surviving implanted cells was in hippocampal areas adjacent to the lateral ventricle (LV; Fig. 4B , left panels). Some surviving cells showed neuronal morphology with axonal extensions (Fig. 4B,  lower right panel) . In addition, the expression of SERT protein in the brain of implanted cell areas was examined further by Western blot. The expression of SERT protein was increased significantly in these hippocampal areas of the SERT KO mice relative to vehicle implant controls (Fig. 4C, D) . SERT protein expression increased gradually beginning at 5 weeks, with increased expression at the 8-week time period following implantation in SERT KO mice compared with sham controls. When the same blot was restained with VMAT2 and β-actin antibodies as positive and negative control proteins, the expression of VMAT2 protein was somewhat increased at 8 weeks (Fig. 4D) , and β-actin protein remained unchanged.
Furthermore, to examine whether these progenitor cells keep their phenotype, these progenitor cells were pretreated with BrdU and then implanted into the hippocampus. The results found that anti-BrdU and anti-5-HT double-stained cells were colocalized in the hippocampal and adjacent brain areas (Fig. 5A ) with a somewhat different time course of survival in the different areas after implantation (Fig. 5B) : 5% (125±70) in the DG of the hippocampus, 77% (1839±329) in hippocampal areas adjacent to the LV areas, and 18% (437±53) just under the CC after 8 weeks implantation. All of these findings suggest that some of the implanted progenitor cells survived and kept their phenotype, expressing SERT protein for at least 8 weeks after implantation.
DISCUSSION
The present study first investigated how to derive serotonergic-like progenitor cells from E14 mouse brain NSCs in vitro for eventual implantation in vivo (Fig. 6, diagram) . We found that specific growth factors, bFGF, FGF-8, and Shh, plus serum-free N-2 medium were required to induce differentiation into neuronal progenitors with a serotonergic phenotype rather than a glial phenotype. The serotonergic phenotype of these cells comprised the following: expression of the serotonin synthetic enzyme, TPH, colocalized with serotonin, as demonstrated using double immunocytochemical staining beginning at 3 weeks and increasing by 8 weeks; expression of SERT protein identified with specific [
125 I]-RTI-55 binding; and 5-HT active transporter identified by specific [ 3 H]-5-HT uptake blocked by SRIs. These serotonergic phenotype progenitor cells with demonstrated expression of functional SERT were maintained by treatment with Shh (42) and FGF-8 in serum-free N-2 culture medium for over 20 weeks.
During our investigations of serotonergic-like progenitor cells, we found that serum-free N-2 medium plays an important role in inhibiting these multipotential progenitors from differentiating into glial phenotype cells. Use of a culture medium with 5% fetal serum led to differentiation of these progenitor cells into an astrocyte phenotype after a 48-to 72-h culture period (data not shown). These findings imply that NSCs will differentiate into various phenotypes depending on their culture environments (43) . In fact, bone marrow stem cells may differentiate into blood cells, liver cells, muscle cells, astrocytes, and neurons, all depending on specific culture environments and growth factors to which the cells are exposed (44) (45) (46) (47) .
Previous studies have found that BDNF affects the brain serotonin system and its functions. Specifically, BDNF enhances the differentiation of a serotonergic phenotype in some cultured cell models (48) (49) (50) . BDNF also modulates 5-HT reuptake function in SERT in cultured cell lines (51) . In the present study, we found that when these progenitor cells were treated with BDNF for 24 h, SERT expression was increased significantly, as evidenced by greater [
125 I]-RTI-55 binding. These findings suggest that BDNF cannot only promote neuronal cell survival and differentiation but also enhances these serotonergic-like progenitor cells to express increased amounts of SERT.
Functional aspects of the serotonergic-like progenitor cells were further characterized to provide potential applications for therapeutic purposes. It is important to note that SERT expressed during embryonic states and early development does not necessarily translate into transporter function. In this regard, we tested whether SERT in these progenitor cells has specific 5-HT uptake function. It was demonstrated that SERT in these cells possessed Na + -dependent uptake activity and that this Na + -dependent 5-HT uptake was mostly abolished by SSRIs such as fluoxetine and citalopram, indicating that it is a specific SERT function.
A major finding from our studies using SERT KO mice was that these progenitor cells implanted into the hippocampus of adult mice survived and kept their phenotype during migration following implantation. We demonstrated that BrdU-labeled cells were double-stained with 5-HT in brain sections of hippocampal areas and also confirmed the identity of these progenitor cells by the EGFP-lentiviral vector labeled after implantation. Taken together, the results showed that these implanted cells could survive for at least 8 weeks in vivo. The expression of SERT protein in brain gradually increased following the implantation in these SERT KO mice. These findings suggest that stable lineage progenitor cells can keep their phenotype and carry the SERT gene into adult mice brain. This study thus advances cell culture biotechnology and developmental cell therapy strategies involving the introduction of targeted genes into adult brains. 3 H]-5-HT uptake in these progenitors. These serotonergic progenitor cells were sensitive to SSRI anti-depressants, as 5-HT uptake was reduced by 95% by fluoxetine (25 µM) and citalopram (50 µM); likewise, the tricycle anti-depressant imipramine (50 µM) reduced 5-HT uptake 90%. All values were statistically significant compared with control values; average data from four to seven separate experiments (means±SEM, P<0.05). B) Brain sections showed that the surviving implanted progenitor cells labeled with EGFP were most dense localized in hippocampal areas adjacent to the LV. Some surviving cells migrated to the dentate gyrus (DG) and differentiated into neuronal cell phenotypes with axonal morphology at 8 weeks following implantation. Vehicle controls did not possess GFP-positive cells (data not shown). Original scale bar = 50 µm. C) Proteins of SERT, VMAT2, and β-actin proteins expressed after implantation. Western blot results showed that the SERT protein gradually increased in hippocampal brain areas of SERT KO mice after implantation compared with sham controls as well as to WT mice controls. The same blot strip was also stained with VMAT2 and β-actin antibodies as positive and negative controls. D) Significant increases of SERT protein expression were quantified compared with sham control. VMAT2 protein expression was more modestly increased compared with sham control by 8 weeks following implantation. figure) ; surviving cells migrated to corpus collosum (CC); and finally, most cells were localized at LV areas. B) Quantitation of surviving cells during the time course after transplantation. Serotonergic progenitors that were positively double-stained in hippocampus were localized 5% in the DG of the hippocampus, 77% in hippocampal areas adjacent to the LV areas, and 18% just under the CC after 8 weeks implantation. 
